<![CDATA[Therapeutic Potential and Early Promise Behind Stem Cell Therapy UX-DA001 in Parkinson Disease]]>
Post Content: Source: Neurology Read More
<![CDATA[How AI and Gene Therapy work in conjunction: Sara Pirzadeh-Miller, MS, CGC]]>
Post Content: Source: Neurology Read More
<![CDATA[Phase 2 VIBRANCE-2 Findings Further Support Orexin-Targeting Treatment Alixorexton in Narcolepsy]]>
Post Content: Source: Neurology Read More
<![CDATA[NeuroVoices: Fabian Somers, PhD, on the First Approved Drug for Thymidine Kinase 2 Deficiency]]>
<![CDATA[Doxecitine/Doxribitine Approval Redefines Care in Thymidine Kinase 2 Deficiency: Fabian Somers, PhD]]>
What APA Is Doing for You: Update on Clozapine REMS
In November 2021, the Food and Drug Administration (FDA) instituted a new Clozapine Risk Evaluation and Mitigation Strategy (REMS) to…
Read More
